Epigral Limited — Important, 09-11-2024: Financial Result Updates

Epigral Limited (formerly Meghmani Finechem Limited) reported its un-audited financial results for Q2 and the first half of fiscal 2024. Revenue from operations reached ₹626.06 crores, with a net profit of ₹80.53 crores for the quarter. The total assets increased to ₹2,978.81 crores, and the company has raised ₹333.05 crores through a Qualified Institutional Placement. The firm continues to focus on manufacturing Chiaro Alkali and its derivatives, reflecting strong operational performance.